What's in Tasly Pharmaceutical Group Co., Ltd's pipeline?

Tasly Pharmaceutical Group Co., Ltd has 21 drugs in our index: 1 marketed, 0 filed, 7 in Phase 3, 6 in Phase 2, 7 in Phase 1.

Which companies overlap with Tasly Pharmaceutical Group Co., Ltd's portfolio?

Top competitors by shared drug class: Ache Laboratorios Farmaceuticos S.A., Ahn-Gook Pharmaceuticals Co.,Ltd, Ain Shams University, Beijing Tide Pharmaceutical Co., Ltd, Bioprojet.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/tasly-pharmaceutical-group-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Tasly Pharmaceutical Group Co., Ltd — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Tasly Pharmaceutical Group Co., Ltd pipeline: 1 marketed, 0 filed, 7 Phase 3, 6 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 7 Phase 3 6 Phase 2 7 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Active drug group	Active drug group	marketed
Qingzhu Granules	Qingzhu Granules	phase 3			Immunology/Inflammation
a simulated agent of Jitongning tablets	a simulated agent of Jitongning tablets	phase 3	ACE inhibitor	ACE	Cardiovascular
Changkang granules	Changkang granules	phase 3	Traditional Chinese medicine		Gastroenterology
Lianxiaxiaopi Granules	Lianxiaxiaopi Granules	phase 3			Gastroenterology
Antiwei Granules	Antiwei Granules	phase 3			Oncology
Jitongning tablets	Jitongning tablets	phase 3			Pain Management / Traditional Chinese Medicine
Susu Xiao'er Zhike Granules	Susu Xiao'er Zhike Granules	phase 3			Immunology

Therapeutic area mix

Gastroenterology · 3
Immunology · 1
Cardiovascular · 1
Oncology · 1
Other · 1
Pain Management / Traditional Chinese Medicine · 1
Immunology/Inflammation · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Ache Laboratorios Farmaceuticos S.A. · 1 shared drug class
Ahn-Gook Pharmaceuticals Co.,Ltd · 1 shared drug class
Ain Shams University · 1 shared drug class
Beijing Tide Pharmaceutical Co., Ltd · 1 shared drug class
Bioprojet · 1 shared drug class
Boryung Pharmaceutical Co., Ltd · 1 shared drug class
Children's Hospital of Fudan University · 1 shared drug class
Ace Cells Lab Limited · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Tasly Pharmaceutical Group Co., Ltd:

Cite this brief

Drug Landscape (2026). Tasly Pharmaceutical Group Co., Ltd — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/tasly-pharmaceutical-group-co-ltd. Accessed 2026-05-16.